BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Vincenzo Ronca, Marco Carbone, Francesca Bernuzzi, Federica Malinverno, Hani S. Mousa, M. Eric Gershwin, Pietro Invernizzi. From pathogenesis to novel therapies in the treatment of primary biliary cholangitisExpert Review of Clinical Immunology 2017; 13(12): 1121 doi: 10.1080/1744666X.2017.1391093
2
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, John M. Vierling, David Adams, Gianfranco Alpini, Jesus M. Banales, Ulrich Beuers, Einar Björnsson, Christopher Bowlus, Marco Carbone, Olivier Chazouillères, George Dalekos, Andrea De Gottardi, Kenichi Harada, Gideon Hirschfield, Pietro Invernizzi, David Jones, Edward Krawitt, Antonio Lanzavecchia, Zhe-Xiong Lian, Xiong Ma, Michael Manns, Domenico Mavilio, Eamon MM. Quigley, Federica Sallusto, Shinji Shimoda, Mario Strazzabosco, Mark Swain, Atsushi Tanaka, Michael Trauner, Koichi Tsuneyama, Ehud Zigmond, M. Eric Gershwin. The challenges of primary biliary cholangitis: What is new and what needs to be doneJournal of Autoimmunity 2019; 105: 102328 doi: 10.1016/j.jaut.2019.102328
3
Jeremy Liu Chen Kiow, Catherine Vincent, Sacha Sidani, Mickael Bouin. High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitisNeurogastroenterology & Motility 2019; 31(11) doi: 10.1111/nmo.13691
4
Dongwei Guo, Tian Zhou, Mariluz Araínga, Diana Palandri, Nagsen Gautam, Tatiana Bronich, Yazen Alnouti, JoEllyn McMillan, Benson Edagwa, Howard E. Gendelman. Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-ThiacytidineJAIDS Journal of Acquired Immune Deficiency Syndromes 2017; 74(3): e75 doi: 10.1097/QAI.0000000000001170
5
Andrew L. Mason. Is PBC a viral infectious disease?Best Practice & Research Clinical Gastroenterology 2018; : 27 doi: 10.1016/j.bpg.2018.06.001
6
Francesca Saffioti, Kurinchi Selvan Gurusamy, Leonardo Henry Eusebi, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn. Pharmacological interventions for primary biliary cholangitisCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011648.pub2
7
David Chascsa, Elizabeth J. Carey, Keith D. Lindor. Old and new treatments for primary biliary cholangitisLiver International 2017; 37(4): 490 doi: 10.1111/liv.13294
8
Maren H. Harms, Henk R. van Buuren, Adriaan J. van der Meer. Improving prognosis in primary biliary cholangitis – Therapeutic options and strategyBest Practice & Research Clinical Gastroenterology 2018; : 85 doi: 10.1016/j.bpg.2018.06.004
9
Guangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, Kevan Cave, Youngkee Hong, John R. Mackey, Harvey J. Alter, Andrew L. Mason. Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver DiseaseJournal of Oncology 2020; 2020: 1 doi: 10.1155/2020/8958192
10
Albert J. Czaja. Clinical Epidemiology of Chronic Liver Diseases2019; : 251 doi: 10.1007/978-3-319-94355-8_16